GGrantIndex
← Leaderboards

Claude B Sirlin

University Of California San Diego

$12,305,192
Attributed
$23,627,200
Total exposure
11
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,627,200 · 11

By mechanism

R01$18,659,985 · 5
R56$2,164,571 · 1
T32$991,439 · 1
R44$947,354 · 1
R43$609,831 · 2
K08$254,020 · 1

Top collaborators

Most similar at University Of California San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Early Diagnosis

Research focus

Early DiagnosisMagnetic Resonance ImagingAffectLiverCirrhosisReference StandardsUnited StatesProspectiveDiagnosisObesityAdultClinical ResearchFatty LiverAmericanDesignLiver DiseasesFatty Acid Glycerol EstersPerformanceMonitorMagnetic ResonanceProtonsDiagnosticSiteImage

Grant awards (44)

Accurate Point of Care Liver Disease Diagnostics, Phase II$947,354
R44 · FY2025 · DK
Quantitative Ultrasound To Diagnose Nonalcoholic Fatty Liver Disease in Children.$680,419
R01 · FY2025 · DK · contact PI
Abbreviated MRI for HCC screening in cirrhotic patients$799,358
R01 · FY2024 · CA
Quantitative Ultrasound To Diagnose Nonalcoholic Fatty Liver Disease in Children.$703,391
R01 · FY2024 · DK · contact PI
Abbreviated MRI for HCC screening in cirrhotic patients$883,658
R01 · FY2023 · CA
Point-of Care MR Device to Estimate T1 Relaxation Time as a Biomarker of Liver Disease (resubmission)$309,974
R43 · FY2023 · EB
Abbreviated MRI for HCC screening in cirrhotic patients$894,475
R01 · FY2022 · CA
Accurate Point of Care Liver Disease Diagnostics$299,857
R43 · FY2022 · DK
Abbreviated MRI for HCC screening in cirrhotic patients$883,588
R01 · FY2021 · CA
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD$723,934
R01 · FY2021 · DK
Abbreviated MRI for HCC screening in cirrhotic patients$947,520
R01 · FY2020 · CA
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD$741,152
R01 · FY2020 · DK
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD$752,932
R01 · FY2019 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD$642,595
R01 · FY2019 · DK · contact PI
Training Clinical Scientists in Radiological Imaging$195,608
T32 · FY2019 · EB
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD$763,999
R01 · FY2018 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD$666,621
R01 · FY2018 · DK · contact PI
Training Clinical Scientists in Radiological Imaging$203,154
T32 · FY2018 · EB · contact PI
Training Clinical Scientists in Radiological Imaging$69,157
T32 · FY2018 · EB · contact PI
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD$797,316
R01 · FY2017 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD$665,303
R01 · FY2017 · DK · contact PI
Training Clinical Scientists in Radiological Imaging$171,308
T32 · FY2017 · EB · contact PI
Training Clinical Scientists in Radiological Imaging$1,512
T32 · FY2017 · EB · contact PI
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD$679,686
R01 · FY2016 · DK · contact PI
Training Clinical Scientists in Radiological Imaging$181,182
T32 · FY2016 · EB · contact PI
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD$713,773
R01 · FY2015 · DK · contact PI
Training Clinical Scientists in Radiological Imaging$169,518
T32 · FY2015 · EB · contact PI
Technical Validation of MRI Biomarkers of Liver Fat$568,774
R01 · FY2014 · DK · contact PI
Technical Validation of MRI Biomarkers of Liver Fat$565,560
R01 · FY2013 · DK · contact PI
Development of MR Based Biomarker Panels for NAFLD _ A NASH CRN Ancillary Study$1,567,298
R56 · FY2012 · DK · contact PI
Technical Validation of MRI Biomarkers of Liver Fat$702,743
R01 · FY2012 · DK · contact PI
Technical Validation of MRI Biomarkers of Liver Fat$605,675
R01 · FY2011 · DK · contact PI
Technical Validation of MRI Biomarkers of Liver Fat$109,431
R01 · FY2011 · DK · contact PI
Technical Validation of MRI Biomarkers of Liver Fat$758,139
R01 · FY2010 · DK · contact PI
Development of MR-based biomarker panels for NAFLD - A NASH CRN Ancillary Study$597,273
R56 · FY2010 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$479,146
R01 · FY2010 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$100,000
R01 · FY2010 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$469,604
R01 · FY2009 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$1,545
R01 · FY2009 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$463,288
R01 · FY2008 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$434,272
R01 · FY2007 · DK · contact PI
MR Imaging of Non-Alcoholic Fatty Liver Disease$462,088
R01 · FY2006 · DK · contact PI
Transducible Molecular Probes for Imaging Tumors$127,010
K08 · FY2004 · CA
Transducible Molecular Probes for Imaging Tumors$127,010
K08 · FY2003 · CA